Goodwin Procter advised Entrada Therapeutics, Inc. on the deal.Entrada Therapeutics, Inc. (Nasdaq: TRDA) announced its global collaboration with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) to focus on…
Entrada Therapeutics’ Global Collaboration with Vertex Pharmaceuticals Incorporated
